patient’s mother, called this nurse and reported that patient still has some left shoulder pain, mainly located in the joint. this has continued since getting her vaccine on 12-31-24. She does play sports and thought maybe it was related to that but shes not sure. She has not been back to the pcp yet. has tried advil for the pain. I advised the vaccine could have been given a bit high on the deltoid, and it should be ok but recommended she contact her doctor for advice and that I would do this report. mom is agreeable to this.

Three hours later began three days of severe muscle spasms in neck, head, body. Lost bladder control, had pains running down my legs. Voice began to hurt, when talking would vibrate in my head. Spasms did not stop for all three,days. months later pains in legs cleared and bladder control restored. I could not get to Drs had just moved here so no primary. Later was given gabapentin and carbamazapine. Saw neurologist who said he would not and could not help me until CDC report issued.

Mom brought patient into the office on 1/17/2025 for a rash that showed up on his abdomen, upper thighs, and diaper area. Per mom, patient had also had a fever x 2 days before rash appeared.

Approximately 30-45 minutes post vaccine administration child began to complain of itching/rash to neck assessed by Medical Coordinator. rash/wells noted bilat arms neck front and back torso Benadryl 50mg administered p.o., dispensed hydrocortizone cream for child to apply. given ice pack for comfort Edema to face hands eyes noted within 10 minutes post initial assessment PCP made aware. administer epi-pen. child taken to hospital ED. child treated in ER with Benadryl IV. IVFluids, prednisone. 1/23/25 @ 7:15am. child denies itching. rash/edema resolving Child will be assessed by PCP this afternoon

Online report of sudden unexpected at death of EUA medical countermeasure recipient. Online report indicates he passed away peacefully on 01/02/2025. Unable to ascertain DOB. DOB is just an estimate. A review of his social media post indicate his second injection was on 05/04/21 and prior post has a picture with his son holding a pharmacy sign. Therefore, its likely he was injected at a pharmacy location. Information on manufacturer, LOT #, DOSE#1 date unavailable. Victim made a post about the presence of black mold on the walls of his apartment within a year of death.

Online report of death by renal failure approximately 4 months after 2nd inoculation of EUA medical countermeasure deemed “COVID-19 vaccine”. Manufacturer, dose dates and lot numbers are unknown. Regardless of manufacturer, either Moderna or Pfizer-Biotech, this adverse event does not appear to have been enumerated into VAERS. As a result, the fatal post inoculation adverse event of this patient will receive the required enumeration as per the EUA.

Reported Symptoms: 10054112:HOSPITALSATION; 100676923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Patient reports that few days ago he had worsening shortness of breath and was prescribed 3 day course of prednisone which he completed yesterday evening. He still had increased shortness of breath with a clear productive cough this morning and presented to the ED with shortness of breath and inability to speak due to shortness of breath. In the ED they did back-to-back treatments of duo nebs, IV solumedrol, IV magnesium and 2L fluids along with IV ceftriaxone. Was admitted for COPD exacerbation secondary to COVID-19. Dexamethasone and remdesivir were started upon admission. Patient experienced symptomatic improvement and was discharged home. Other Relevant HX: PMHx of COPD GOLD D not on home O2, HTN, HLD, PAD, gout, melanoma s/p resection and colonic pseudo-obstruction presenting to the ED for shortness of breath. Admitted for COPD exacerbation secondary to COVID-19 infection. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination

Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Pt was admitted to the hospital due to severe abdominal pain. Was found to have gastritis/duodenitis/cholecystitis as primary diagnosis. Several days into the hospitalization, pt reported cough, congestion, sore throat, runny nose, generalized weakness, and loss of taste. Tested positive for COVID 19 infection – no hypoxemia. Discussed option for tx w/ remdesivir given age >65. Discussed risks/benefits and patient opted for treatment. Experienced symptom improvement and was discharged home. Other Relevant HX: PMH of diverticulitis, hyperlipidemia, DM, and hypertension, presented with diffuse abdominal pain. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination

Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREAKTHROUGH INFECTION; 10084268:COVID-19; Narrative: Pt presents with 4 days of atypical chest pain found to have elevated troponin in the ED. Pt was admitted to medicine for further ACS workup. Cardiology was consulted and heparin drip was initiated on admission along with aspirin and high intensity statin. Initially discussed possibility of type II MI vs COVID myocarditis. Serial troponins continued to rise. Pt underwent LHC with pRCA stenting. No medications were started for treatment for COVID-19. Chest pain resolved during hospitalization & patient was discharged home after 1 day. Other Relevant HX: Patient with PMH of HTN, T2DM complicated by peripheral neuropathy, HLD who presents with 4 days of central chest pain/pressure. Hx of smoking. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination

Reported Symptoms: 10054112:HOSPITALISATION; 10067923:VACCINE BREATHROUGH INFECTION; 10084268: COVID-19; Narrative: HOSPITAL COURSE: Patient was admitted to the hospital for further work-up of bradycardia, dizziness, and hypoxia. He was placed on supplemental O2 2L/min initially. Of note, patient was found to have COVID 19 for which he had just finished a Paxlovid course (started 6/25/24). From the COVID perspective patient was doing well and is inflammatory markers were unremarkable. Patient was saturating greater than 92% on room air. Patient also had orthostatics done for which he was positive where he dropped 10 mmHg and diastolic. Because of this IV fluids were given to the patient and responded appropriately. Of note, patient was also found to have bouts of bradycardia for which patient was asymptomatic at the time. on 7/4, patient was hemodynamically stable and symptomatic bradycardia. Other Relevant HX: Patient was prescribed Paxlovid in outpatient setting prior to hospitalization. Patient presented to the hospital for asymptomatic bradycardia and hypoxemia that may have been related to the COVID-19 infection since patient was still testing positive in the hospital. Other: Hospitalization due to Covid-19 infection after having received Covid-19 Vaccination